BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25152774)

  • 1. Relationship between gut hormones and glucose homeostasis after bariatric surgery.
    Sala PC; Torrinhas RS; Giannella-Neto D; Waitzberg DL
    Diabetol Metab Syndr; 2014; 6(1):87. PubMed ID: 25152774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery.
    Federico A; Dallio M; Tolone S; Gravina AG; Patrone V; Romano M; Tuccillo C; Mozzillo AL; Amoroso V; Misso G; Morelli L; Docimo L; Loguercio C
    In Vivo; 2016; 30(3):321-30. PubMed ID: 27107092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Entero-Endocrine Cell Biology to Surgical Interventional Therapies for Type 2 Diabetes.
    Guimarães M; Pereira SS; Monteiro MP
    Adv Exp Med Biol; 2021; 1307():273-297. PubMed ID: 32016913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narrative review: effect of bariatric surgery on type 2 diabetes mellitus.
    Vetter ML; Cardillo S; Rickels MR; Iqbal N
    Ann Intern Med; 2009 Jan; 150(2):94-103. PubMed ID: 19153412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Diabetes Improvement Following Bariatric/Metabolic Surgery.
    Batterham RL; Cummings DE
    Diabetes Care; 2016 Jun; 39(6):893-901. PubMed ID: 27222547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery?
    Papamargaritis D; le Roux CW
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Implication of Gut Hormones in the Regulation of Energy Homeostasis and Their Role in the Pathophysiology of Obesity.
    Koliaki C; Liatis S; Dalamaga M; Kokkinos A
    Curr Obes Rep; 2020 Sep; 9(3):255-271. PubMed ID: 32647952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of gut hormones in glucose homeostasis.
    Drucker DJ
    J Clin Invest; 2007 Jan; 117(1):24-32. PubMed ID: 17200703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A perspective on metabolic surgery from a gastroenterologist.
    Syu YF; Inui A; Chen CY
    J Pharmacol Sci; 2017 Feb; 133(2):61-64. PubMed ID: 28237320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incretins: clinical physiology and bariatric surgery--correlating the entero-endocrine system and a potentially anti-dysmetabolic procedure.
    Lamounier RN; Pareja JC; Tambascia MA; Geloneze B
    Obes Surg; 2007 May; 17(5):569-76. PubMed ID: 17658012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of PYY in Pancreatic Islet Physiology and Surgical Control of Diabetes.
    Guida C; Stephen S; Guitton R; Ramracheya RD
    Trends Endocrinol Metab; 2017 Aug; 28(8):626-636. PubMed ID: 28533020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individuals with type 2 diabetes have higher density of small intestinal neurotensin-expressing cells.
    Ferreira FP; Pereira SS; Costa MM; Guimarães M; Albrechtsen NJW; Holst JJ; Nora M; Monteiro MP
    Mol Cell Biochem; 2023 Dec; 478(12):2779-2787. PubMed ID: 36920577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery.
    Holst JJ
    Curr Opin Pharmacol; 2013 Dec; 13(6):983-8. PubMed ID: 24161809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurohormonal Changes in the Gut-Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery.
    Martinou E; Stefanova I; Iosif E; Angelidi AM
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of various gastrointestinal procedures on β-cell function in obesity and type 2 diabetes.
    Malin SK; Kashyap SR
    Surg Obes Relat Dis; 2016 Jul; 12(6):1213-9. PubMed ID: 27568472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The altered enteroendocrine reportoire following roux-en-Y-gastric bypass as an effector of weight loss and improved glycaemic control.
    Moffett RC; Docherty NG; le Roux CW
    Appetite; 2021 Jan; 156():104807. PubMed ID: 32871202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered gut and adipose tissue hormones in overweight and obese individuals: cause or consequence?
    Lean ME; Malkova D
    Int J Obes (Lond); 2016 Apr; 40(4):622-32. PubMed ID: 26499438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal peptide changes after bariatric and minimally invasive surgery: Relation to diabetes remission.
    Castagneto Gissey L; Casella Mariolo J; Mingrone G
    Peptides; 2018 Feb; 100():114-122. PubMed ID: 29412812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal hormones and bariatric surgery-induced weight loss.
    Ionut V; Burch M; Youdim A; Bergman RN
    Obesity (Silver Spring); 2013 Jun; 21(6):1093-103. PubMed ID: 23512841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass?
    Chondronikola M; Harris LL; Klein S
    J Intern Med; 2016 Nov; 280(5):476-486. PubMed ID: 27739136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.